3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Motor Activity
36
Neoplasms
17
Breast Neoplasms
14
Carcinoma, Non-Small-Cell Lung
6
Polycystic Ovary Syndrome
4
Lymphoma
4
Lung Neoplasms
4
Sarcopenia
3
Prostatic Neoplasms
3
Fatigue
3
Colorectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Obesity
2
Malnutrition
2
Lymphedema
2
Insulin Resistance
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Weight Cycling
1
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Interventions
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Metformin
1
Immunotherapy, Adoptive
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Filgrastim
1
Exercise
1
Emapalumab
1
Cyclophosphamide
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cytopenia
×
Exercise
×
Clear all
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled